Research review
Thymosin alpha-1, LL-37 and VIP: peptides in innate and adaptive immunity research
14 November 2026 · 5 min read
Immunity is usually divided into innate immunity, which responds quickly and without specificity, and adaptive immunity, which recognises particular antigens and remembers them. The two lines work together, and laboratories usually study them in cell cultures and in animal models. The three peptides discussed below illustrate this division well: Thymosin alpha-1 is described mainly in the context of T lymphocyte maturation, LL-37 in the early response of neutrophils and monocytes, and VIP in receptor signalling in inflammatory cells and blood vessels.
Thymosin alpha-1: a thymic peptide of 28 residues
Thymosin alpha-1 is built from 28 amino acid residues, and its N-terminus is acetylated. The molecule was isolated from a fraction of the thymus, the organ historically linked to research on T lymphocytes. Its molecular weight is 3108.3 g/mol and its molecular formula is C129H215N33O55. Knowing these parameters makes it easier to convert concentrations and compare successive experimental series.
In vitro studies have described the effect of this peptide on the maturation and differentiation of T lymphocytes and on the function of dendritic cells, which present antigens to lymphocytes. Authors linked these effects to changes in cytokine release, such as interleukin 2 and interferon gamma. Because the mechanism has several levels, results are best interpreted with reference to a specific cell type and incubation time.
LL-37: the only human cathelicidin
LL-37 is a peptide of 37 amino acid residues and the only cathelicidin found in humans. Cathelicidins form a family of innate immunity peptides. LL-37 is released from the precursor protein hCAP-18: after cleavage, the fragment located at the C-terminal end of the molecule is freed. The peptide is positively charged and amphipathic, meaning one face of the helix is hydrophilic and the other is hydrophobic. In lipid membrane environments it adopts an alpha-helical structure, and this arrangement determines how the molecule interacts with membranes and with other proteins.
In vitro work describes LL-37 binding to negatively charged bacterial membranes and disrupting their integrity. Laboratory models have also examined neutrophil and monocyte chemotaxis, activation of the FPR2 receptor, and modulation of cytokine secretion. The peptide is further analysed in the context of biofilm formation and breakdown, and in cell cultures related to wound healing.
VIP: a neuropeptide from the secretin and glucagon family
Vasoactive intestinal peptide (VIP) consists of 28 amino acid residues and belongs to the secretin and glucagon family. It signals through two receptors, VPAC1 and VPAC2, which belong to the G protein-coupled receptor family. After binding to the receptor, cAMP levels in the cell rise, which starts a further signalling cascade. This pathway is well described in neurobiology and vascular physiology, which is why VIP often serves as a reference point in studies of the autonomic nervous system.
In isolated vessel preparations and in animal models, relaxation of smooth muscle has been described. In immune cell cultures, VIP is analysed as a modulator of the inflammatory response, and results depend on the cell type and peptide concentration. The molecule has a molecular weight of 3325.8 g/mol and the formula C147H238N44O42S.
Three peptides in one comparison
| Feature | Thymosin alpha-1 | LL-37 | VIP |
|---|---|---|---|
| Chain length | 28 residues | 37 residues | 28 residues |
| Origin or family | thymic fraction | cathelicidins, innate immunity | secretin and glucagon family |
| Molecular weight | 3108.3 g/mol | 4493.3 g/mol | 3325.8 g/mol |
| Main research areas | T lymphocytes, dendritic cells | neutrophils, membranes, biofilm | VPAC1 and VPAC2 receptors, blood vessels |
| Form in the shop | lyophilisate, 5 and 10 mg | lyophilisate, 5 mg | lyophilisate, 5 and 10 mg |
How to read results in the literature
These three peptides differ not only in structure but also in the strength of their evidence. Most data on Thymosin alpha-1, LL-37 and VIP come from in vitro studies and animal models, not from large clinical programmes. When interpreting results, several points deserve attention.
The first is concentration. The same peptide may behave differently at low and at high concentrations, so an accurate calculation of the working solution matters. The second is the model. A culture of one cell type does not represent the whole immune system, so a result from one model should not be carried over to another without further verification. The third is purity. Impurities of similar mass can change a result, which is why HPLC analysis and mass confirmation by MS matter already when choosing a reagent.
When designing comparisons, it also helps to plan separate control groups for each peptide and to set evaluation criteria before a series begins. This makes it possible to separate the effect of the molecule from the effect of the experimental conditions.
Innate and adaptive immunity in one project
Comparing these three molecules is useful when a research question concerns the relationship between immune lines. Thymosin alpha-1 opens questions about T lymphocytes and antigen-presenting cells, LL-37 about the early response of neutrophils and interactions with membranes, and VIP about receptor signalling in inflammatory cells and vessels. Each of these pathways can be studied on its own and then checked for overlap. Such a layout helps distinguish a direct effect from a secondary one, meaning a change caused by cells that react to the first signal.
A structural analogy, however, does not predetermine results. Molecules with different sequences can act at different levels, even when they sit in the same research area.
Quality and shipping of reagents
All three products are lyophilised and have a purity of at least 99%, confirmed by HPLC. We check molecular mass by MS, so both composition and molecular weight are verified. Orders are dispatched within 24 hours. In Poland the parcel goes to an InPost parcel locker, and across Europe it is delivered by DPD. Thymosin alpha-1, LL-37 and VIP are listed in the shop with the specifications above.
Working in the laboratory
Store the lyophilisate of each of these peptides at -20 °C, tightly closed and protected from moisture and light. Before opening a vial, let it reach room temperature to limit water condensation on the powder.
Reconstitute just before use, usually in bacteriostatic water or in a solvent consistent with the study protocol. Add the liquid slowly along the wall of the vial and do not shake the solution vigorously. Store the ready solution at 2-8 °C and prepare aliquots immediately, because repeated freezing and thawing damages peptides. The concentration calculator makes it easy to work out the working concentration.